Skip to main content
Clinical Trials/NCT02154451
NCT02154451
Unknown
Phase 1

Transient Infrared Imaging for Early Detection of Skin Cancer

Skinfrared LLC3 sites in 1 country400 target enrollmentAugust 2013
ConditionsSkin Cancer

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Skin Cancer
Sponsor
Skinfrared LLC
Enrollment
400
Locations
3
Primary Endpoint
To detect skin cancers with >90% sensitivity and >50% specificity using infrared imaging
Last Updated
11 years ago

Overview

Brief Summary

The hypothesis or study goal is to determine whether functional dynamic infrared imaging can be used for melanoma and other skin cancer screening and/or diagnosis.

Registry
clinicaltrials.gov
Start Date
August 2013
End Date
December 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Skinfrared LLC
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All lesion in easily accessible places
  • Lesion less than 3.5 cm

Exclusion Criteria

  • Any minors
  • Lesion close to vital organs

Outcomes

Primary Outcomes

To detect skin cancers with >90% sensitivity and >50% specificity using infrared imaging

Time Frame: 5 years

We are developing a screening algorithm than can compute data from infrared pictures and give us a threshold below which all the cases are benign and above which is malignant. Our primary outcome is to detect all the malignant cases with more than 90% sensitivity and all the benign cases with more than 50% specificity,

Study Sites (3)

Loading locations...

Similar Trials